Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stable Renal Recipients”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Post-approval studies (Phase 4)Ended earlyNCT00332839
What this trial is testing

Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients.

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 93
Testing effectiveness (Phase 2)Study completedNCT01294020
What this trial is testing

Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®

Who this might be right for
Intestine TransplantationKidney TransplantationLung Transplantation+2 more
Astellas Pharma Europe Ltd. 81
Testing effectiveness (Phase 2)Study completedNCT01791491
What this trial is testing

Pharmacokinetics, Safety and Tolerability of Single-dose Belatacept in Adolescent Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Bristol-Myers Squibb 16
Post-approval studies (Phase 4)Study completedNCT00713284
What this trial is testing

Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic

Who this might be right for
Renal Transplantation
California Pacific Medical Center Research Institute 29
Post-approval studies (Phase 4)WithdrawnNCT01269684
What this trial is testing

Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals
Post-approval studies (Phase 4)Study completedNCT06044493
What this trial is testing

MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Chong Kun Dang Pharmaceutical 158
Post-approval studies (Phase 4)Study completedNCT01334333
What this trial is testing

Comparison of Medication Adherence Between Once and Twice Daily Tacrolimus in Stable Renal Transplant Recipients

Who this might be right for
Renal DiseaseRenal Transplant
University of British Columbia 46
Not applicableUnknownNCT02908139
What this trial is testing

Noninvasive Perioperative Monitoring of Arterial Stiffness, Volume and Nutritional Status in Stable Renal Transplant Recipients

Who this might be right for
Arterial CalcificationAortic StiffnessHigh Blood Pressure+1 more
Medical University of Warsaw 40
Not applicableStudy completedNCT01884480
What this trial is testing

Renal Function and Pharmacogenetics in Renal Transplant Recipients Converted From Tac BID to Tac OD

Who this might be right for
Real Function Post Conversion From Prograf to AdvagrafExamin Ethnicity and Pharmacogenetics of the Cohort Requiring Dose Adjustment Post-conversion
Unity Health Toronto 60
Post-approval studies (Phase 4)Ended earlyNCT00991510
What this trial is testing

Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients

Who this might be right for
Stable Renal Transplant Recipients
Teva Branded Pharmaceutical Products R&D, Inc. 43
Large-scale testing (Phase 3)Study completedNCT00284934
What this trial is testing

Enteric-coated Mycophenolate Sodium (EC-MPS) With Reduced-dose Tacrolimus Versus EC-MPS With Standard-dose Tacrolimus in Stable Kidney Transplant Recipients

Who this might be right for
Kidney Diseases
Novartis 94
Post-approval studies (Phase 4)Study completedNCT01990118
What this trial is testing

Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients

Who this might be right for
End Stage Renal Failure
Penang Hospital, Malaysia 106
Early research (Phase 1)Study completedNCT01710033
What this trial is testing

CP-690,550 In Stable Kidney Transplant Patients

Who this might be right for
Kidney Transplant
Pfizer 28
Post-approval studies (Phase 4)Study completedNCT01742676
What this trial is testing

A Single Center, Open-label, Randomized, Pilot Study to Evaluate the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF®, Versus Tacrolimus Twice Daily, PROGRAF® in Stable Renal Recipients

Who this might be right for
Renal TransplantationKidney TransplantationStable Renal Recipients
Astellas Pharma Korea, Inc. 100
Not applicableStudy completedNCT02852941
What this trial is testing

Assessment of Volumetric Hemodynamic Parameters and Nutritional Status in Stable Renal Transplant Recipients

Who this might be right for
Cardiac Output, LowHigh Blood Pressure
Medical University of Warsaw 80
Post-approval studies (Phase 4)Study completedNCT03270462
What this trial is testing

CNS Study of Patients Switching From Tacrolimus to Envarsus

Who this might be right for
Renal Transplant Patients
University of Colorado, Denver 20
Not applicableUnknownNCT06013358
What this trial is testing

DdcfDNA in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Seoul National University Hospital 200
Not applicableStudy completedNCT03812419
What this trial is testing

Esomeprazole or Pantoprazole in Renal Transplantation

Who this might be right for
Kidney Transplant; Complications
Future University in Egypt 47
Post-approval studies (Phase 4)Study completedNCT02034747
What this trial is testing

Assess the Efficacy and Safety of Advagraf® Switching From Cyclosporine Between the Group That Was Treated With a 50% Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Astellas Pharma Korea, Inc. 150
Large-scale testing (Phase 3)Study completedNCT00384137
What this trial is testing

A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney Recipients

Who this might be right for
Transplantation
Astellas Pharma Inc 128
Next Page